Gene Insertion Tech with SalioGen CEO Jason Cole

ASGCT Podcast Network - June 11, 2024

SalioGen CEO Jason Cole joins host Emily Walsh Martin, PhD to explore the company's cutting-edge transposase-based gene insertion technology presented at the ASGCT Annual Meeting.

Follow the ASGCT Podcast Network wherever you listen to podcasts!


In this Very Special Episode, Emily Walsh Martin, PhD explores the cutting-edge transposase-based technology presented by SalioGen at the ASGCT Annual Meeting in which they achieved gene insertion without double-strand breaks. Join us as Jason Cole, CEO at SalioGen, takes us on a captivating journey through the company's groundbreaking work, including their initial data in Stargardt disease using LNP delivery to photoreceptors.

But that's not all! Discover Jason's unconventional path from small molecules to genetic medicines and gain insights into the strategic value of using a target product profile to guide development decisions.

Finally, we delve into the transformative potential of genetic medicine, bridging the gap from bench to bedside to payer-to-patient access.

And before we dive in, a quick reminder: The ASGCT Policy Summit (Sept 23-24 in DC or online) is an absolute must for R&D scientists, analytical experts, clinical researchers, and program managers seeking a comprehensive understanding of genetic medicine development. Don't miss this crucial conversation between regulators, payors, patients, caregivers, and developers.


Music by: https://www.steven-obrien.net/
Bright New Morning - Steven O'Brien

(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)

Related Articles


CRISPR and Beyond with Vertex CSO David Altshuler, MD, PhD—ASGCT's The Issue

July 16, 2024

Targeting STAT3 in Tumors with Oligo-PROTAC with Dr. Marcin Kortylewski

Listen to this episode of The Molecular Therapy Podcast - July 09, 2024
Molecular Therapy

AAV Capsid Production with Drs. Mario Mietzsch and Robert McKenna

Molecular Therapy Podcast - June 18, 2024
Molecular Therapy

A New Vision for MTMCD with EiC Dr. Mohamed Abou-el-Enein

ASGCT Podcast Network - June 04, 2024